首页> 外文OA文献 >Immunoradiometric assay of human proinsulin and partially processed proinsulin with use of monoclonal antibody and streptavidin-biotin labeling.
【2h】

Immunoradiometric assay of human proinsulin and partially processed proinsulin with use of monoclonal antibody and streptavidin-biotin labeling.

机译:使用单克隆抗体和链霉亲和素-生物素标记对人胰岛素原和部分加工的胰岛素原进行免疫放射测定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The sensitive and specific immunoradiometric assay is described for human proinsulin and its intermediate peptides (65-66 split and 32-33 split proinsulin). We developed a monoclonal antibody-based two-site immunoradiometric assay with use of streptavidin-biotin labeling. The detection limits of the assays lie in the range of 0.5-2.0 pM. In the proinsulin assay proinsulin cross-reacted 66% with 65-66 split proinsulin but not with insulin or 32-33 split proinsulin. In the assay of 65-66 split proinsulin it does not cross-react with insulin, proinsulin or 32-33 split proinsulin. In the 32-33 split proinsulin assay it cross-reacted 84% with proinsulin and 60% with 65-66 split proinsulin. The precision (C.V.) of the assays was less than 15% over the various concentration. The mean concentrations of insulin, proinsulin, 65-66 split proinsulin and 32-33 proinsulin in eight young male subjects in the fasting state were (pM +/- S.E.M.) 20 +/- 3.6, 2.3 +/- 0.3, undetectable (less than 1.0) and 2.1 +/- 0.7 and at the maximum reached during an oral glucose tolerance test, 150 +/- 26, 9.9 +/- 1.4, 3.8 +/- 0.6 and 19.7 +/- 6.0 respectively.
机译:描述了针对人胰岛素原及其中间肽(65-66拆分和32-33拆分胰岛素原)的灵敏且特异性的免疫放射测定法。我们开发了使用链霉亲和素-生物素标记的基于单克隆抗体的两点免疫放射测定法。测定的检测极限在0.5-2.0pM的范围内。在胰岛素原测定中,胰岛素原与65-66分裂胰岛素原交叉反应66%,但不与胰岛素或32-33分裂胰岛素原交叉反应。在65-66分裂胰岛素原的测定中,它不会与胰岛素,胰岛素原或32-33分裂胰岛素原发生交叉反应。在32-33分裂胰岛素原测定中,它与胰岛素原交叉反应84%,与65-66分裂胰岛素原交叉反应60%。在各种浓度下,测定的精密度(C.V.)小于15%。八名处于禁食状态的年轻男性受试者中的胰岛素,胰岛素原,65-66分裂胰岛素原和32-33胰岛素原的平均浓度为(pM +/- SEM)20 +/- 3.6、2.3 +/- 0.3,无法检测到(较少大于1.0)和2.1 +/- 0.7,并且在口服葡萄糖耐量测试期间达到的最大值分别为150 +/- 26、9.9 +/- 1.4、3.8 +/- 0.6和19.7 +/- 6.0。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号